SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

Advanced Micro Devices is trending as investors aggressively rotate into CPU-related AI plays following positive sector sentiment and optimistic analyst upgrades. The community is sharply divided, with bulls pointing to long-term secular growth and infrastructure dominance while bearish traders voice concerns over extreme valuation multiples, extended RSI levels, and the sustainability of this rapid parabolic move.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is trending as a major retail and momentum favorite, fueled by significant investor enthusiasm over potential partnerships with hyperscalers and its role in AI data center infrastructure. The community is heavily focused on a potential short squeeze, given the intense trading volume and reports of restricted share availability, while debates persist between optimistic long-term holders and bearish concerns regarding the company's current revenue levels.

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia Therapeutics is currently surging due to the FDA lifting the clinical hold on its Phase 3 MAGNITUDE trial, signaling a significant derisking of its CRISPR-based heart disease therapy. Community discussion is dominated by bullish sentiment regarding the potential for a major short squeeze, as participants highlight the stock's high short interest and the significant valuation gap remaining since the trial's original halt.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

Direxion Daily Semiconductor Bull 3X Shares (SOXL) is experiencing an unprecedented, parabolic rally driven by intense AI-sector optimism, historic institutional buying, and a record-breaking streak of consecutive green days. The community is deeply polarized, with bulls emboldened by sustained momentum and massive gains, while bears are increasingly vocal about the lack of fundamental justification, citing extreme technical overextension and looming recession risks as signs that a sharp correction is imminent.

"What's Updog?" is a Community Led token.

UpDog

UpDog is capturing attention through a combination of sustained community momentum, aggressive whale accumulation, and successful organic growth efforts that have kept the token trending. Investors are actively discussing the project's multi-year history on Solana and its presence on the Jupiter strict list, with many looking for the next major leg up in its market trajectory.

Dumb SEND IT

Dumb SEND IT ($DSIT) is gaining significant traction as a community-driven meme project that emphasizes rapid, collective "sending" to build momentum toward its market cap goals. The community is heavily focused on HODLing through volatility, active promotion to onboard new degens, and community-wide airdrops to reward early supporters as they aim to hit key milestones.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X Shares

Investors in the Direxion Daily Semiconductor Bear 3X Shares are facing intense volatility as the semiconductor sector continues its unprecedented streak of gains, leaving bears sidelined and frustrated by aggressive market melt-ups. Community members are actively debating the timing of a potential sector pullback, with many questioning the sustainability of current valuation multiples amidst widespread concerns about extreme overbought technical indicators and systemic market decay.

Terra is a decentralized financial payment network that rebuilds the traditional payment stack on the blockchain. Luna is the reserve currency of the Terra platform. It has three core functions: i) mine Terra transactions through staking, ii) ensure the price stability of Terra stablecoins and iii) provide incentives for the platform’s blockchain validators.

Terra Luna Classic

Terra Luna Classic is experiencing heightened market attention as community members speculate on potential supply burns and project revivals while actively monitoring upcoming clarity legislation. Investors are engaging in spirited discussions regarding the token's long-term utility, with many holding positions in anticipation of a significant price reversal.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is seeing a historic surge, fueled by an earnings beat that shifted investor sentiment on the role of CPUs in AI infrastructure and triggered a massive short squeeze. The community is actively debating the sustainability of this parabolic move, with many traders watching closely for a potential pullback while bulls point to new foundry partnerships and deep-pocketed institutional backing as evidence of a long-term turnaround.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is experiencing a massive rally driven by insatiable AI data center demand for high-performance NAND flash memory and anticipation surrounding its upcoming earnings. The community is actively tracking a potential stock split, while retail investors remain locked in a heated debate between holding for further parabolic gains and betting on an inevitable correction.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Annie Yoshiyama Sells 9,586 Shares of Allogene Therapeutics (NASDAQ:ALLO) Stock

Allogene Therapeutics, Inc. (NASDAQ:ALLO - Get Free Report) SVP Annie Yoshiyama sold 9,586 shares of the business's stock in a transaction on Tuesday, April 21st. The shares were sold at an average...

Allogene Therapeutics (NASDAQ:ALLO) SVP Annie Yoshiyama Sells 9,586 Shares

Allogene Therapeutics, Inc. (NASDAQ:ALLO - Get Free Report) SVP Annie Yoshiyama sold 9,586 shares of the company's stock in a transaction dated Tuesday, April 21st. The stock was sold at an average...

Allogene Therapeutics (NASDAQ:ALLO)  Shares Down 6%   - Should You Sell?

Allogene Therapeutics (NASDAQ:ALLO) Trading Down 6% - What's Next...

HC Wainwright Issues Optimistic Estimate for ALLO Earnings

Allogene Therapeutics, Inc. (NASDAQ:ALLO - Free Report) - Analysts at HC Wainwright boosted their Q2 2026 EPS estimates for Allogene Therapeutics in a report released on Thursday, April 16th. HC Wainwright analyst R. Burns now forecasts that the company will post earnings of ($0.15) per share for th...

Allogene Therapeutics, Inc. (NASDAQ:ALLO) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Allogene Therapeutics, Inc. (NASDAQ:ALLO - Get Free Report) has received an average rating of "Moderate Buy" from the fifteen research firms that are presently covering the company, Marketbeat...

Allogene Therapeutics (NASDAQ:ALLO) Trading Up 13.1% Following Analyst Upgrade

Allogene Therapeutics (NASDAQ:ALLO) Trading 13.1% Higher After Analyst Upgrade...

Allogene Therapeutics (NASDAQ:ALLO) Upgraded to "Neutral" at JPMorgan Chase & Co.

JPMorgan Chase & Co. raised Allogene Therapeutics from an "underweight" rating to a "neutral" rating in a research report on Thursday...

Allogene Therapeutics (NASDAQ:ALLO) Shares Gap Down - Time to Sell?

Allogene Therapeutics (NASDAQ:ALLO) Shares Gap Down - Should You Sell...

Traders Buy Large Volume of Put Options on Allogene Therapeutics (NASDAQ:ALLO)

Allogene Therapeutics, Inc. (NASDAQ:ALLO - Get Free Report) was the recipient of unusually large options trading on Wednesday. Stock investors purchased 4,437 put options on the company. This is an...

Allogene Therapeutics (NASDAQ:ALLO) Upgraded to Strong-Buy at Jefferies Financial Group

Jefferies Financial Group raised Allogene Therapeutics to a "strong-buy" rating in a research note on Monday...

Allogene Therapeutics, Inc. operates as a clinical stage immuno-oncology company pioneering the development and commercialization of genetically engineered allogeneic T cell therapies for the treatment of cancer. The firm develops a pipeline of off-the-shelf T cell product candidates that are designed to target and kill cancer cells. Its engineered T cells are allogeneic, which are derived from healthy donors for intended use in any patient. The company was founded by Arie S. Belldegrun, David D. Chang, David M. Tanen, and Joshua A. Kazam in November 2017 and is headquartered in South San Francisco, CA.

Current Price	$2.31
Prev Close	$2.35
Open	$2.33
Dividend Yield	0.00%
50-Day Moving Average	$2.39
Beta	1.63
Avg. Volume	5.46M
PE Ratio	-2.66

52-Week High	$4.46
52-Week Low	$0.8621
Market Capitalization	$765.25M
EPS (Annual)	-$0.8652
Price to Book	1.81
Revenue Per Employee	$0.00

ALLO
Allogene Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ALLO News

ALLOAllogene Therapeutics Inc